Unknown

Dataset Information

Explainable AI enables clinical trial patient selection to retrospectively improve treatment effects in schizophrenia.


ABSTRACT:

Background

Heterogeneity among patients' responses to treatment is prevalent in psychiatric disorders. Personalized medicine approaches-which involve parsing patients into subgroups better indicated for a particular treatment-could therefore improve patient outcomes and serve as a powerful tool in patient selection within clinical trials. Machine learning approaches can identify patient subgroups but are often not "explainable" due to the use of complex algorithms that do not mirror clinicians' natural decision-making processes.

Methods

Here we combine two analytical approaches-Personalized Advantage Index and Bayesian Rule Lists-to identify paliperidone-indicated schizophrenia patients in a way that emphasizes model explainability. We apply these approaches retrospectively

SUBMITTER: Mellem MS 

PROVIDER: S-EPMC8135147 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature